Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue, Psoriasis, Rash, Skin discolouration, Skin exfoliation
Clinical narrative: Did not get her 2nd dose; Aacivated my psoriasis; Breakout including face peeling really bad/lesions inside her ears, on her scalp, on her ear lobes, and around her mouth/still has lesions near her eyes and one near her ear; Breakout including face peeling really bad/lesions inside her ears, on her scalp, on her ear lobes, and around her mouth/still has lesions near her eyes and one near her ear; Discoloration around the mouth area; Breakout including face peeling really bad/lesions inside her ears, on her scalp, on her ear lobes, and around her mouth/still has lesions near her eyes and one near her ear; This spontaneous case was reported by a consumer and describes the occurrence of PSORIASIS (Aacivated my psoriasis), SKIN EXFOLIATION (Breakout including face peeling really bad/lesions inside her ears, on her scalp, on her ear lobes, and around her mouth/still has lesions near her eyes and one near her ear), SKIN LESION (Breakout including face peeling really bad/lesions inside her ears, on her scalp, on her ear lobes, and around her mouth/still has lesions near her eyes and one near her ear), SKIN DISCOLOURATION (Discoloration around the mouth area) and RASH (Breakout including face peeling really bad/lesions inside her ears, on her scalp, on her ear lobes, and around her mouth/still has lesions near her eyes and one near her ear) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Psoriatic arthritis since 01-Jan-2014, Hay fever, Hyperthyroidism since 04-Apr-1996, Diabetes (Since 15+ years), Neck pain and Muscle spasms. Concomitant products included GLYBURIDE;METFORMIN and LIRAGLUTIDE (VICTOZA) for Diabetes, CYCLOBENZAPRINE for Muscle spasms, GABAPENTIN for Neck pain, ROSUVASTATIN CALCIUM and ACETYLSALICYLIC ACID (BABY ASPIRIN) for Prevention, LISINOPRIL and FOLIC ACID for Prophylaxis, ADALIMUMAB (HUMIRA) for Psoriasis, LEVOTHYROXINE for Thyroid disorder NOS.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Jan-2021, the patient experienced PSORIASIS (Aacivated my psoriasis), SKIN EXFOLIATION (Breakout including face peeling really bad/lesions inside her ears, on her scalp, on her ear lobes, and around her mouth/still has lesions near her eyes and one near her ear), SKIN LESION (Breakout including face peeling really bad/lesions inside her ears, on her scalp, on her ear lobes, and around her mouth/still has lesions near her eyes and one near her ear), SKIN DISCOLOURATION (Discoloration around the mouth area) and RASH (Breakout including face peeling really bad/lesions inside her ears, on her scalp, on her ear lobes, and around her mouth/still has lesions near her eyes and one near her ear). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Did not get her 2nd dose). The patient was treated with CLOBETASOL PROPIONATE (CLOBETASOL 0.05%) for Adverse event NOS, at an unspecified dose and frequency and HYDROCORTISONE for Adverse event NOS, at a dose of 2.5 percent cream. On 05-May-2021, PSORIASIS (Aacivated my psoriasis), SKIN EXFOLIATION (Breakout including face peeling really bad/lesions inside her ears, on her scalp, on her ear lobes, and around her mouth/still has lesions near her eyes and one near her ear), SKIN LESION (Breakout including face peeling really bad/lesions inside her ears, on her scalp, on her ear lobes, and around her mouth/still has lesions near her eyes and one near her ear), SKIN DISCOLOURATION (Discoloration around the mouth area) and RASH (Breakout including face peeling really bad/lesions inside her ears, on her scalp, on her ear lobes, and around her mouth/still has lesions near her eyes and one near her ear) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (Did not get her 2nd dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 06-Aug-2021: Follow up received contains reporter's phone number and email added and Patient details include race, ethnic group, height and weight and relevant history(except psoriatic arthritis)updated. In product tab, dose number, anatomical location, batch number, vaccine facility information updated. Concomitant drugs(glyburide-metformin, gabapentin,victoza,levothyroxine,rosuvastatin calcium, Lisinopril, cyclobenzaprine, folic acid, baby aspirin and humira indication)updated. Treatment drugs updated. Event(activated my psoriasis)added.